PharmaNews PARO presents: Some very important recommendations for the care of patients with kidney disease in the face of the COVID-19 pandemic! The virus that causes the Coronavirus Disease is called acute severe respiratory syndrome coronavirus 2 (Severe Acute Caul Respiratory Syndrome coronavirus 2, SARS-CoV-2). It can be transmitted from one infected person’s respiratory droplets to the mouth, eyes and/or nose of another person. Currently, there is no officially approved or effective therapeutic treatment against COVID-19. However, the therapeutic potential of different drugs, such as remdesivir, lopinavir/ritonavir, chloroquine, hydroxychloroquine, interferon, and the modification of the IECA/ARA II prescription are being explored.
Researchers explore the impact of COVID-19 on renal disease and offered solutions in three different scenarios: 1. Patients with stage 5 chronic kidney disease (CKD-5) in chronic renal replacement therapy (RRT) 2. Patients who develop acute kidney injury (AKI) 3. Evaluation of potential kidney donors CKD patients on RRT: Hemodialysis, peritoneal dialysis and transplant patients are a high-risk group for the development of complications. The greatest possibility of infection will occur in patients receiving treatment in hemodialysis centers. ●
Patients must receive seasonal flu (Influenza) vaccine
●
Symptomatic and/or confirmed patients with COVID-19 they should not come into direct contact with other susceptible patients
●
Suspect patients should be separated from other patients, in addition to putting a mask on.
●
They must be evaluated in order to defer dialysis to the last shift day of a 14 day quarantine or until confirming the diagnosis.
●
Compliance with hand washing or alcohol application must be ensured before and after contact with each patient.
●
In the case of presenting symptoms suggestive of infection or of known contact with a confirmed case, your immediate supervisor should be informed before the patient goes to the dialysis unit
Patients who have an episode of ARI: ●
Have exclusive hospital areas for infected patients that have the ability to administer dialysis, both at a moderate and intensive level of care